Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,636
datasets available to search
ShareScore release 0.9.0
Dataset results
1,636 results for “Head and Neck cancer”
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov study NCT04590963. IPD Sharing: YES. Countries: 23. Publications: 1.
A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients
ClinicalTrials.gov study NCT03821272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer
ClinicalTrials.gov study NCT04220775. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)
ClinicalTrials.gov study NCT00095875. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov study NCT00410826. IPD Sharing: Not stated. Countries: 1. Publications: 3.
LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
ClinicalTrials.gov study NCT01856478. IPD Sharing: YES. Countries: 8. Publications: 1.
Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer
ClinicalTrials.gov study NCT03521570. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
ClinicalTrials.gov study NCT03258554. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer
ClinicalTrials.gov study NCT02369874. IPD Sharing: YES. Countries: 24. Publications: 1.
Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers
ClinicalTrials.gov study NCT05120947. IPD Sharing: NO. Countries: 1. Publications: 6.
Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov study NCT00425750. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis
ClinicalTrials.gov study NCT03030859. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
ClinicalTrials.gov study NCT05442957. IPD Sharing: YES. Countries: 1. Publications: 1.
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) 2.0
ClinicalTrials.gov study NCT03831100. IPD Sharing: NO. Countries: 1. Publications: 5.
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
ClinicalTrials.gov study NCT03237325. IPD Sharing: NO. Countries: 5. Publications: 3.
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
ClinicalTrials.gov study NCT00140556. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
ClinicalTrials.gov study NCT01566435. IPD Sharing: NO. Countries: 1. Publications: 2.
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
ClinicalTrials.gov study NCT01345669. IPD Sharing: Not stated. Countries: 29. Publications: 2.
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
ClinicalTrials.gov study NCT00047008. IPD Sharing: NO. Countries: 1. Publications: 7.
TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
ClinicalTrials.gov study NCT01711658. IPD Sharing: Not stated. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.